Aurelia Healthcare – Business Plan

Investment-grade business plan for Aurelia Healthcare Holdings (Pty) Ltd — a USD 240-million hybrid raise (AfDB-led) to build an integrated tertiary and quaternary specialist hospital platform in South Africa, scaling revenue from USD 12 million to USD 215 million by Year 5 (USD 461 million at stabilization) at a base-case 19.4% equity IRR and a 4.7× money multiple.

Confidential Business Plan

Aurelia Healthcare

An integrated tertiary and quaternary specialist hospital platform for South Africa — anchored by Aurelia Medical City in Johannesburg and built out across regional specialist hospitals into a full healthcare ecosystem, clinically-led and purpose-built for the post-NHI, development-finance environment — structured as an investment-grade USD 240-million hybrid opportunity for the African Development Bank, co-financiers, senior lenders and equity partners.

Legal Entity
Aurelia Healthcare Holdings (Pty) Ltd
Location
Johannesburg, South Africa
Capital Sought
USD 240 million
Structure
Senior debt + equity + mezzanine (AfDB-led)
Revenue (Yr1 → Yr5)
USD 12m → USD 215m
Revenue (Stabilized)
USD 461 million
Stabilized EBITDA Margin
31–35%
Equity IRR (Base)
19.4%
Money Multiple (Base)
4.7×
Sector
Healthcare & Specialist Hospitals
The Opportunity

South Africa hosts the most sophisticated private healthcare ecosystem on the continent, yet three listed operators — Netcare, Mediclinic and Life Healthcare — control roughly 83% of private hospital beds and 90% of admissions, leaving room for a clinically-led, capital-efficient and technology-forward challenger purpose-built for the post-NHI, development-finance era. Aurelia captures this with an integrated specialist hospital platform — Aurelia Medical City in Johannesburg, then regional hospitals and a full healthcare ecosystem — scaling from 420 to 870 beds and from USD 12 million to USD 215 million of revenue by Year 5 (USD 461 million and a 34% EBITDA margin at stabilization). A USD 240-million hybrid raise led by the African Development Bank delivers a base-case 19.4% equity IRR and a 4.7× money multiple, with a JSE main-board IPO as the preferred exit.

Plan Contents

This investor-grade business plan is organised into the sections below. Each section is a dedicated page — select any to explore the full detail.

Confidentiality & Disclaimer

This document has been prepared by Aurelia Healthcare Holdings
(Proprietary) Limited (the “Sponsor”) solely for the purpose of
providing potential financiers, lenders, investors, and qualified
institutional partners (collectively, the “Recipients”) with information
about a proposed integrated tertiary healthcare infrastructure platform
in the Republic of South Africa (the “Project”).

The information contained in this document is strictly confidential
and is provided on the express understanding that it will be used only
for the purpose of evaluating a possible financing or investment in the
Project. Recipients agree not to disclose, copy, distribute, reproduce,
or otherwise circulate this document or any of its contents, in whole or
in part, without the prior written consent of the Sponsor.

All financial projections, operational forecasts, and strategic
statements contained herein are based on management assumptions,
third-party market intelligence, and industry data believed to be
reliable as of the date of preparation. Forward-looking statements
involve known and unknown risks, uncertainties, and other factors that
may cause actual results to differ materially from those expressed or
implied. No representation or warranty, express or implied, is made by
the Sponsor or its advisors as to the accuracy or completeness of any
forward-looking statement.

This document is not an offer to sell, nor a solicitation of an offer
to buy, any security or financial instrument. Any decision to invest in
or finance the Project should be made only after independent due
diligence, review of the definitive transaction documents, and
consultation with appropriate legal, tax, accounting, and financial
advisors.

Distribution of this document in certain jurisdictions may be
restricted by law. Recipients should inform themselves of, and observe,
any such restrictions. The Sponsor accepts no liability for any failure
on the part of any Recipient to comply with such restrictions.

Any reproduction or use of this document for purposes other than
those for which it has been provided is expressly prohibited. By
accepting this document, the Recipient agrees to be bound by the
foregoing restrictions and to return the document, together with any
copies, upon request.

Document Preparation Prepared by: The Office of the Chief Executive Officer, Aurelia Healthcare Holdings (Pty) Ltd, in collaboration with the Group Chief Financial Officer and external advisors. Independent technical and commercial reviews were conducted by tier-one professional services firms covering market sizing, clinical operations modeling, construction quantity surveying, regulatory & legal opinion, and financial model audit.

Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of Aurelia Healthcare Holdings (Pty) Ltd.